|
(866) 998-8855
 |
 |
|
|
 |
Home > Health Conditions > Cholesterol Formulas >
L-Carnitine is a vitamin-like
nutrient that is synthesized in the body, using the amino acids lysine and
methionine as precursors. Because the body produces L-Carnitine on its own, it
cannot be classified as a vitamin, even though it has functions similar to B
vitamins. Fumarate is also a natural compound found in the body. Fumarate serves
as an intermediate in the Krebs cycle, a key cellular energy-producing process.
L-Carnitine and Fumarate both play important roles in energy metabolism.
Best L-Carnitine
contains BIOSINT™ L-Carnitine Fumarate, which is made in Italy by Sigma Tau
Health Science. It is derived from a base of pharmaceutical-grade L-Carnitine
manufactured using an FDA-approved process that fully complies with
international monograph standards for carnitine production. No biotechnology or
genetically modified organisms are involved. L-Carnitine Fumarate is certified
GMO free, BSE safe, pesticide free and Kosher. It is also ISO 9002 certified and
NNFA GMP certified. L-Carnitine Fumarate is highly stable and bioavailable.
Known as a
global leader in L-Carnitine research, Sigma Tau holds numerous patents for
production of L-Carnitine, and its L-Carnitine derivatives are used in clinical
trials. Sigma Tau Health Science has the only FDA-approved (1984) pharmaceutical
batch process system for consistent L-Carnitine quality, and has been
manufacturing L-Carnitine derivatives for 30 years.

Benefits
Helps the body burn fat for energy*
L-Carnitine promotes energy production in cells by transporting fatty acids into
the mitochondrion. Its primary function is to transfer long-chain fatty acids
across the inner mitochondrial membrane. Fatty acid molecules are activated to
coenzyme A (CoA) esters in the cytoplasm of the cell, and then esterified to L-Carnitine.
The combination of a fatty acid molecule and L-Carnitine is called “acyl-carnitine.”
Much of the body's L-Carnitine content is stored in the form of acyl-carnitine.1
The
mitochondrion is the cell’s energy-generating furnace. Called an “organelle,”
the mitochondrion is a self-contained structure inside the cell. Like all
cellular structures, the mitochondrion is surrounded by a membrane. This
membrane is an impenetrable barrier to acyl-CoA esters; passage across the
membrane requires L-Carnitine as a transporter. On the inside of the
mitochondrial membrane, the acyl-CoA esters are made available to be metabolized
through the process of beta oxidation. One of the key metabolic byproducts of
this process is acetyl-CoA, also called “active acetate,” which enters the Krebs
cycle (also known as the “citric acid cycle”) to supply fuel for production of
ATP, the cell’s primary energy “currency.” L-Carnitine shuttles excess fatty
acid residues out of the mitochondrion, and in this role is essential for
preventing toxic buildup of fatty acids inside the mitochondrion.
Evidence
suggests that L-Carnitine and short chain acyl-carnitine esters can protect the
mitochondrion from adverse effects of drugs and toxic chemicals. L-Carnitine has
been shown to protect animals form cardiotoxins and decrease mortality rate in
animals with diphtheria, due to this cardioprotective effect.2
Helps maintain a healthy heart and cardiovascular system*
Muscle
tissue contains a high concentration of L-Carnitine. With its constant energy
needs, heart muscle tissue is especially rich in L-Carnitine. If the body’s
ability to biosynthesize L-Carnitine is compromised, energy production in muscle
tissue is impaired, and a toxic buildup of fatty acids can occur.3
Defective production of L-Carnitine by the body can result from a variety of
factors, including kidney or liver malfunction, increased catabolism or the
inability of tissues to extract and retain L-Carnitine from the blood.
Along with
glucose and lactate, fatty acids are the primary oxidation fuel for the heart. A
considerable amount of scientific data from animal experiments indicates that L-Carnitine
protects the heart under conditions of hypoxia, or low oxygen. In addition to
the oxidation of fat for energy in the cell, L-Carnitine is involved in the
metabolism of glucose.4
Evidence of L-Carnitine’s role in glucose metabolism was uncovered in a small
trial on 9 diabetic individuals. Given intravenously, L-Carnitine improved
insulin-mediated glucose utilization and insulin sensitivity.5
Depletion
of the body’s L-Carnitine supply is linked to various abnormal states,
especially of the heart muscle. The effect of L-Carnitine on hypoxic
(oxygen-starved) isolated heart muscle tissue has been studied.6
At high concentrations, L-Carnitine demonstrates a clear-cut ability to
potentiate the contractility of isolated heart muscle tissue, indicating the L-Carnitine
has a strengthening effect on the heart. L-Carnitine has been shown to improve
the performance of rats subjected to fatigue test.
Research
has revealed that in animals and humans with defective heart muscle, the amount
of free L-Carnitine (not bound to fatty acids) is reduced. Administration of L-Carnitine
to hamsters prevents damage to the heart muscle. Given to humans with angina, L-Carnitine
was found to improve exercise tolerance. In a small study, patients with
congestive heart failure showed gains in heart function with oral consumption of
L-Carnitine, reportedly by restoring normal oxidation of fatty acids.7
In heart valve replacement patients, L-Carnitine has been shown to increase the
valve tissue levels of ATP, pyruvate and creatine phosphate, which are key
cellular energy substrates. In a controlled study, L-Carnitine was administered
to 38 patients prior to open heart surgery. Prior to surgery, heart circulatory
function, as assessed by measurements of hemodynamics, was “good” in all 38.
While there was evidence of a “preserving” effect of L-Carnitine on heart cells,
no differences in cardiac performance were observed. These results suggest that
noticeable improvements in heart muscle performance with L-Carnitine are most
likely to occur in people with compromised hearts.8
It has
been suggested that L-Carnitine favorably influences blood lipids. Preliminary
evidence of this was seen in a small open trial on 26 patients who took 3 grams
of L-Carnitine daily for 40 days. Blood levels of cholesterol and triglycerides
dropped substantially, while the ratio of total to HDL cholesterol–– a known
marker of cardiovascular health––markedly improved.9
While L-Carnitine
is not a treatment for heart disease, (nor should it be used as a substitute for
medical treatment) the results of these and other studies suggest that oral
consumption of L-Carnitine has a beneficial influence on maintaining a healthy
heart and cardiovascular system.
Safety
Suggested Adult Use: Take 1 to 4 capsules daily.
L-Carnitine is considered to be very safe for oral consumption. L-Carnitine
is generally well tolerated, even at doses as high as 15 grams daily. Toxicity
or overdosage has not been reported.10
Does Not
Contain: milk, egg, wheat, corn, sugar, sweeteners, starch, salt, or
preservatives.
Scientific References
1. Wagenmakers, A. L-Carnitine
supplementation and performance in man. Brouns, F. ed. Advances in Nutrition and
Top Sport. Med Sport Sci. Basel, Karger, 1991;32:110-27.
2. Arrigoni-Martelli, E., Caso, V. Carnitine protects mitochondria and removes
toxic acyls from xenobiotics. Drugs Exptl. Clin. Res. 2001;27(1):27-49)
3. Pepine, C.J. The therapeutic potential of carnitine in cardiovascular
disorders. Clinical Therapeutics 1991;13(1):2-21.
4. Calvani, M., Reda, E., Arrigoni-Martelli, E. Regulation by carnitine of
myocardial fatty acid and carbohydrate metabolism under normal and pathological
conditions. Basic Research in Cardiology 2000;95(2):75-83.
5. Capaldo, B. et al. Carnitine improves peripheral glucose disposal in
non-insulin-dependent diabetic patients. Diabetes Research and Clinical Practice
1991;14:191-96.
6. Fanelli, O. Carnitine and acetyl-carnitine, natural substances endowed with
interesting pharmacological properties. Life Sciences 1978;23:2563-2570.
7. Kobayashi, A., Masumura, Y., Yamazaki, N. L-Carnitine treatment for
congestive heart failure-experimental and clinical study. Japanese Circulation
Journal 1992;56:86-94.
8. Pastoris, O. et al. Effect of L-Carnitine on myocardial metabolism: results
of a balanced, placebo-controlled, double-blind study in patients undergoing
heart surgery. Pharmacological Research 1998;37(2):115-22.
9. Pola, P. et al. Carnitine in the therapy of dyslipidemic patients. Current
Therapeutic Research 1980;27(2):208-16.
10. L-Carnitine. PDR for Nutritional Supplements. First Ed. 2001.Montvale,
NJ:Medical Economics.
|